Advertisement

Die Diagnose der Sepsis

  • L. Engelmann
Chapter
  • 645 Downloads

Auszug

Die frühe Diagnostik der Sepsis ist das Nadelöhr für die weitere Senkung der Sepsissterblichkeit. Inzwischen liegen Befunde vor, dass, vergleichbar mit akutem Myokardinfarkt und Schlaganfall, dem Faktor Zeit eine wichtige Rolle zukommt. Demgegenüber gibt es keine allgemein akzeptierte Sepsisdiagnostik, die der Forderung nach früher Diagnose und der Unabhängigkeit vom Erfahrungsstand des jeweiligen Arztes Rechnung tragen könnte.

Schlüsselwörter

Sepsis Diagnose Infektionsmarker Procalcitonin Inflammationsreaktion 

Literatur

  1. 1.
    Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRefGoogle Scholar
  2. 2.
    Poeze M, Ramsay G, Gerlach H et al (2004) An international sepsis survey: a study of doctors’ knowledge and perception of sepsis. Crit Care 8: R409–R413PubMedCrossRefGoogle Scholar
  3. 3.
    ACCP/SCCM Consensus Conference Committee (1992) Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRefGoogle Scholar
  4. 4.
    Brunkhorst FM, Engel C, Weite T et (2005) Prevalence of infection in German intensive care units results from the German Prevalence Study. Infection 33(Suppl 1):47Google Scholar
  5. 5.
    Reinhart K, Brunkhorst FM, Bloos F et al (2006) S2 Leitlinien der Deutschen Sepsis-Gesellschaft e.V. und der Deutschen Interdisziplinären Vereinigung für Intensivund Notfallmedizin. AWMF-Leitlinien-Register Nr. 079/001Google Scholar
  6. 6.
    Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250–1256PubMedCrossRefGoogle Scholar
  7. 7.
    Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214PubMedCrossRefGoogle Scholar
  8. 8.
    Seifert H, Abele-Horn M, Fätkenheuer G et al (2006) Sepsis-Blutkulturdiagnostik. In: Mauch H, Podbielski A, Herrmann M (Hrsg) Mikrobiologisch-infektiologische Qualitätsstandards. MiQ 3. Urban & Fischer, München, S1–S155Google Scholar
  9. 9.
    Mewald Y, Hamann GF (2005) Versagen des zentralen, peripheren und vegetativen Nervensystems. Intensivmed 42:250–263Google Scholar
  10. 10.
    Seifried E (1995) Disseminierte intravasale Gerinnung. Hämostaseologie 15:57–64Google Scholar
  11. 11.
    Taylor FB, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Heamost 86: 1327–1330Google Scholar
  12. 12.
    Wu AHB (2001) Increased troponin in patients with sepis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27:959–961 11 PubMedCrossRefGoogle Scholar
  13. 13.
    Witthaut R, Busch C, Fraunberger P et al (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left venticular dysfunction. Intensive Care Med 29:1696–1702PubMedCrossRefGoogle Scholar
  14. 14.
    Carpentier J, Luyt CE, Fulla Y et al (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660–665CrossRefGoogle Scholar
  15. 15.
    Latronico N, Fenzi F, Recupero D et al (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582PubMedCrossRefGoogle Scholar
  16. 16.
    Schmidt H, Müller-Werdan U, Hoffmann T et al (2005) Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 33:1994–2002PubMedCrossRefGoogle Scholar
  17. 17.
    Volk HD, Reinke P, Döcke WD (1999) Immunological monitoring of the inflammatory process: which variables? When to assess? Eur J Surg 584 (Suppl):70–72Google Scholar
  18. 18.
    Vincent JL, deMedoza A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in tntensive care units: results of a multicenter, prospective study. Crit Care Med 26: 1793–1800PubMedGoogle Scholar
  19. 19.
    Levy MM, Macias WL, Vincent JL et al (2005) Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33:2194–2201PubMedCrossRefGoogle Scholar
  20. 20.
    Brun-Buisson C, Doyon F, Carlet J et al (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUsand wards of 24 hospitals. Am J Respir Crit Care Med 154:617–624PubMedGoogle Scholar
  21. 21.
    Danner RL, Elin RJ, Hosseini JM, Wesley RA et al (1991) Endotoxemia in human septic shock. Chest 99:169–175PubMedCrossRefGoogle Scholar
  22. 22.
    Engelmann L, Al Zoebi A, Pilz U, Werner M et al (1996) Die Bedeutung der Endotoxinbestimmung bei Sepsis. Intensivmed 33:253–259Google Scholar
  23. 23.
    Assicot M, Gendrei D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518PubMedCrossRefGoogle Scholar
  24. 24.
    Müller B, Becker KL, Schächinger H et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983PubMedCrossRefGoogle Scholar
  25. 25.
    Steinbach G, Rau B, Debard AL et al (2004) Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® system. Clin Chem Lab Med 42:440–449PubMedCrossRefGoogle Scholar
  26. 26.
    Clec’h C, Ferriere F, Karoubi P et al (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32: 1166–1169CrossRefGoogle Scholar
  27. 27.
    Christ-Crain M, Jaccard-Stolz D, Bingisser R et al (2004) Effect of procalcitonin-guided treatment an antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607PubMedCrossRefGoogle Scholar
  28. 28.
    Cohen J, Brun-Buisson C, Torres A, Jorgenden J (2004) Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 32 (Suppl): S466–S494PubMedCrossRefGoogle Scholar
  29. 29.
    Brunkhorst FM, Engel C, Stüber F et al (2005) Diagnoszic criteria for severe sepsis and septic shock: a representative survey among german ICU physicians-results from the German Prevalence Study. Infection33(Suppl. 1):47Google Scholar
  30. 30.
    Linscheid P, Seboek D, Schaer DJ et al (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent manocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–1721PubMedCrossRefGoogle Scholar
  31. 31.
    Kruse, ER, Langefeld I, Jaeger K, Külpmann WR (2000) Procacitonin a new diagnostic tool in complications following liver transplantation. Intensive Care Med 26:S187–S192CrossRefGoogle Scholar
  32. 32.
    Rau B, Krüger CM, Schilling MK (2004) Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 389:134–144PubMedCrossRefGoogle Scholar
  33. 33.
    Lateef A, Khoo SM, Lee KH (2005) Procalcitonin in hypoxic brain damage. Intensive Care Med 31:494PubMedCrossRefGoogle Scholar
  34. 34.
    Delevaux I, Andre M, Colombier M et al (2003) Can procalcitonin measurement help in differential ing between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62:337–340PubMedCrossRefGoogle Scholar
  35. 35.
    Brunkhorst FM (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:88–889CrossRefGoogle Scholar
  36. 36.
    Engelmann L, Petros S, Gundelach K, Wegscheider K (2006) Die Bedeutung des „second hit“ für den Sepsisverlauf. Intensivmed 43:189–201CrossRefGoogle Scholar
  37. 37.
    Herbarth S, Holeckova K, Froidevaux et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402Google Scholar
  38. 38.
    Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38: 483–493PubMedCrossRefGoogle Scholar
  39. 39.
    Kylänpää-Bäck ML, Takala A, Kemppainen E et al (2001) Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin inpredicting the severity of acute pancreatitis. Crit Care Med 29:63–69PubMedCrossRefGoogle Scholar
  40. 40.
    Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M (2002) Predictive value of procalcitonin and interleukin-6 in critically ill patients with suspected sepsis. Intensive Care Med 28:1220–1225PubMedCrossRefGoogle Scholar
  41. 41.
    Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as marker of bacterial infections: a systematic review and meta-analysis. CID 39:206–217CrossRefGoogle Scholar
  42. 42.
    Liaudat S, Dayer E, Praz G, Bille J, Troillet N (2001) Usefulness of procalcitonin serum levels for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 20:524–527PubMedCrossRefGoogle Scholar
  43. 43.
    Manegold C, Schmiedel S, Chiwakata CB, Dietrich M (2003) Procalcitonin serum levels in tertian malaria. Malar J 2:34PubMedCrossRefGoogle Scholar
  44. 44.
    Jereb M, Kotar T (2006) Usefulness of procalcitonin to differentiate typical from atypical community-aquired pneumonia. Wien Klin Wochenschr 118:170–174PubMedCrossRefGoogle Scholar
  45. 45.
    Masid M, Gutierrez F, Shum C et al (2005) Usfulness of procalcitonin levels in community-aquired pneumonia according to the patients outcome research team pneumonia team severity index. Chest 128:2223–2229CrossRefGoogle Scholar
  46. 46.
    Boussekey N, Leroy O, Alfandari S et al (2006) Procalcitonin kinetics in the prognosis of severe communityaquired pneumonia. Intensive Care Med 32:469–472PubMedCrossRefGoogle Scholar
  47. 47.
    Giamarellou H, Giamerellos-Bourboulis EJ, Repoussis P et al (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 10:628–633PubMedCrossRefGoogle Scholar
  48. 48.
    Whicher J (1998) C-reaktives Protein (CRP) In: Thomas L (Hrsg) Labor und Diagnose, 5. Aufl. TH-Books Verlagsgesellschaft mbH, Frankfurt/ Main, S717–S724Google Scholar
  49. 49.
    Wahl HG, Herzum I, Renz H (2003) Spsis und Sepsismarker-Update. J Lab Med 27:431–439CrossRefGoogle Scholar
  50. 50.
    Meisner M, Tschaikowsky K, Palmears T, Schidt J (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Critical Care 3:45–50PubMedCrossRefGoogle Scholar
  51. 51.
    Calandra T, Gerain J, Heumann D et al (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytikines. Am J Med 91:23–29PubMedCrossRefGoogle Scholar
  52. 52.
    Martin C, Saux P, Mege JL et al (1994) Prognostic value of serum cyteokines in septic shock. Intensive Care Med 20:272–277PubMedCrossRefGoogle Scholar
  53. 53.
    Marty C, Misset B, Tamion F et al (1994) Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 22:673–679PubMedCrossRefGoogle Scholar
  54. 54.
    Parson PE, Moss M (1996) Early dedection and markers of sepsis. Clin Chest Med 17:199–212CrossRefGoogle Scholar
  55. 55.
    Walley KR, Lukacs NW, Standiford TJ et al (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733–4738PubMedGoogle Scholar
  56. 56.
    Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321S–329SPubMedGoogle Scholar
  57. 57.
    Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. JID 181:176–180PubMedCrossRefGoogle Scholar
  58. 58.
    Brauner JS, Rohde LE, Clausell N (2000) Circulating endithelin-1 and tumor necrosis factor-a: early predictors of mortality in patients with septic shock. Intensive Care Med 26:305–313PubMedCrossRefGoogle Scholar
  59. 59.
    Oberholzer A, Oberholzer C, Moldawer LL (2002) Interleukin-10: a complex role in the pathogenesis of sepsis syndroms and ist potential as an anti-inflammatory drug. Crit Care Med 30 (Suppl):S58–S63CrossRefGoogle Scholar
  60. 60.
    Volk HD, Reinke P, Krausch D et al (1995) HLA-DR-Expression auf Monozyten bei Peritonitis und Sepsis Möglichkeiten eines therapeutischen Ansatzes. Chir Gastroenterol 11(Suppl 2):34–41CrossRefGoogle Scholar
  61. 61.
    Döcke WD, Syrbe U, Meinecke A et al (1994) Verbesserung der Monozytenfunktion ein therapeutischer Ansatz? In: Update in Intensive Care and Emergency Medicine Bd 18. Springer, S 473–488Google Scholar
  62. 62.
    Hörner C, Bouchon A, Bierhaus A et al (2004) Bedeutung der angeborenen Immunantwort in der Sepsis. Anästhesist 53:10–28CrossRefGoogle Scholar
  63. 63.
    Perry SE, Mostafa SM, Wenstone R et al (2003) Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med 29:1245–1252PubMedCrossRefGoogle Scholar
  64. 64.
    Oczenski W, Krenn H, Jilch R et al (2003) HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29:1253–1257PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag 2006

Authors and Affiliations

  • L. Engelmann
    • 1
  1. 1.Einheit für Multidisziplinäre IntensivmedizinUniversitätsklinikum Leipzig A.ö.R.LeipzigGermany

Personalised recommendations